Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06287398
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2024-02-07
Brief Title:
Epcoritamab Epcor-Containing Combination Salvage Therapy Followed by ASCT Epcor Consolidation in Patients With Relapsed LBCL
Sponsor:
Australasian Leukaemia and Lymphoma Group
Organization:
Australasian Leukaemia and Lymphoma Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-11
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-07
First Submit QC Date:
February 28 2024
Study First Post Date:
2024-03-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-19
Last Update Post Date:
2024-03-01
Last Update Post Date Type:
ACTUAL